According to OpGen 's latest financial reports the company's current revenue (TTM) is $3.07 M. In 2022 the company made a revenue of $2.6 M a decrease over the years 2021 revenue that were of $4.3 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $3.07 M | 17.76% |
2022 | $2.6 M | -39.45% |
2021 | $4.3 M | 2.17% |
2020 | $4.21 M | 20.46% |
2019 | $3.49 M | 18.75% |
2018 | $2.94 M | -8.24% |
2017 | $3.21 M | -20.24% |
2016 | $4.02 M | 27.49% |
2015 | $3.15 M | -23.47% |
2014 | $4.12 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Lexicon Pharmaceuticals
LXRX | $1.2 M | -60.75% | ๐บ๐ธ USA |
Enzo Biochem ENZ | $12.8 M | 317.10% | ๐บ๐ธ USA |